<?xml version="1.0" encoding="UTF-8"?>
<p>In vitro, ribavirin exhibits mild antiviral activity against PIV [
 <xref ref-type="bibr" rid="CR58_21">58</xref>]. No clear efficacy of aerosolized ribavirin was found in small, uncontrolled cohorts of patients with HM [
 <xref ref-type="bibr" rid="CR34_21">34</xref>, 
 <xref ref-type="bibr" rid="CR139_21">139</xref>]. Early initiation of ribavirin therapy has been proposed to enhance efficacy [
 <xref ref-type="bibr" rid="CR140_21">140</xref>]. No studies have evaluated intravenous immunoglobulins or RSV-specific immunoglobulins, which contain high titres of PIV-specific immunoglobulins.
</p>
